Personal information

No personal information available

Activities

Collapse all

Education and qualifications (2)

University of Manchester: Manchester , GB

2017 to 2021 | PhD
Education
Source: Self-asserted source
Robert Morgan

University College London: London, GB

2005 to 2010 | MB BS
Education
Source: Self-asserted source
Robert Morgan

Professional activities (1)

Royal College of Physicians: London, GB

Membership
Source: Self-asserted source
Robert Morgan

Works (50 of 61)

Items per page:
Page 1 of 2

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer

British Journal of Cancer
2024-11-16 | Journal article | Author
DOI: 10.1038/s41416-024-02874-6
SOURCE-WORK-ID:

f8da744c-0e61-4f21-91b0-ac31349383bb

EID:

2-s2.0-85209190178
Contributors: Robert Morgan; Xin Wang; Bethany M. Barnes; Laura Spurgeon; Aurore Carrot; Daniel Netto; Jurjees Hasan; Claire Mitchell; Zena Salih; Sudha Desai et al.
Source: check_circle
University of Manchester - PURE

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene

Genetics in Medicine
2024-10-01 | Journal article | Author
DOI: 10.1016/j.gim.2024.101230
SOURCE-WORK-ID:

c8ac1302-715f-4269-9bf9-275293bad277

EID:

2-s2.0-85202815034
Contributors: Robert Morgan; George Burghel; Nicola Flaum; Helene Schlecht; Andrew Clamp; Jurjees Hasan; Claire Mitchell; Zena Salih; Sarah Moon; Martin Hogg et al.
Source: check_circle
University of Manchester - PURE
grade
Preferred source (of 2)‎

Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation

NAR cancer
2024-07-16 | Journal article | Author
DOI: 10.1093/narcan/zcae030
SOURCE-WORK-ID:

2a1959a3-2026-4a30-af7a-3a677bf7e24a

EID:

2-s2.0-85198986391
Contributors: Camilla Coulson-Gilmer; Samantha Littler; Bethany Barnes; Rosie Brady; Holda A Anagho; Nisha Pillay; Malini Dey; William Macmorland; Daniel Bronder; Louisa Nelson et al.
Source: check_circle
University of Manchester - PURE
grade
Preferred source (of 2)‎

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
2024-07-01 | Journal article | Author
DOI: 10.1136/ijgc-2024-005455
PMID: 38724236
Contributors: Murphy AD; Porter C; Ann White ; Irving A; Richard Adams; Ray R; Casbard A; Reem Mahmood; Karanth S; Zhou C et al.
Source: Self-asserted source
Robert Morgan

Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: lower rates for 5-years post chemotherapy

Genetics in Medicine
2024-06-03 | Journal article | Author
DOI: 10.1016/j.gim.2024.101172
SOURCE-WORK-ID:

54ab035a-3dfb-4ec6-82c4-48ea410bc12c

EID:

2-s2.0-85197083262
Contributors: Gareth Evans; Robert Morgan; Emma j. Crosbie; sacha howell; Claire Forde; Anthony Howell; Fiona Lalloo; Emma r. Woodward
Source: check_circle
University of Manchester - PURE
grade
Preferred source (of 2)‎

Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN
2024-04-18 | Journal article
DOI: 10.6004/jnccn.2023.7331
PMID: 38866043
Contributors: Manchanda R; Sun L; Sobocan M; Rodriguez IV; Wei X; Kalra A; Samuel Oxley; Sideris M; Fierheller CT; Morgan RD et al.
Source: Self-asserted source
Robert Morgan

Real-World Concordance between Germline and Tumour <i>BRCA1/2</i> Status in Epithelial Ovarian Cancer

Cancers
2023-12 | Journal article | Author
DOI: 10.3390/cancers16010177
Contributors: Robert Morgan; George J. Burghel; Helene Schlecht; Andrew R. Clamp; Jurjees Hasan; Claire L. Mitchell; Zena Salih; Joseph Shaw; Sudha Desai; Gordon C. Jayson et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability

Chromosome Research
2023-08-17 | Journal article | Author
DOI: 10.1007/s10577-023-09731-x
Part of ISSN: 1573-6849
Contributors: Louisa Nelson; Bethany Barnes; Anthony Tighe; Samantha Littler; Camilla Coulson-Gilmer; Anya Golder; Sudha Desai; Robert Morgan; Joanne McGrail; Stephen Taylor
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial.

Clinical Cancer Research
2023-07-01 | Journal article
DOI: 10.1158/1078-0432.ccr-22-3282
PMID: 36799931
Source: Self-asserted source
Robert Morgan

Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.

International Journal of Gynecological Cancer
2023-04-24 | Journal article
DOI: 10.1136/ijgc-2022-004211
PMID: 37072323
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1.

Journal of Medical Genetics
2023-03-09 | Journal article
DOI: 10.1136/jmg-2022-109055
PMID: 36894311
PMC: PMC10313943
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

Cancers
2023-01 | Journal article | Author
DOI: 10.3390/cancers15030730
Contributors: Robert Morgan; George J Burghel; Nicola Flaum; Michael Bulman; Philip Smith; Andrew R. Clamp; Jurjees Hasan; Claire L. Mitchell; Zena Salih; Emma R. Woodward et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors.

NAR cancer
2022-11-12 | Journal article
DOI: 10.1093/narcan/zcac036
PMID: 36381271
PMC: PMC9653014
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer.

Journal of Clinical Pathology
2022-06-23 | Journal article
DOI: 10.1136/jcp-2022-208369
PMID: 35738887
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?

British Journal of Cancer
2022-03-08 | Journal article
DOI: 10.1038/s41416-022-01773-y
PMID: 35260807
Source: Self-asserted source
Robert Morgan

c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial.

BMC Medicine
2022-02-11 | Journal article
DOI: 10.1186/s12916-022-02270-y
PMID: 35144591
PMC: PMC8832801
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status.

Sexual Medicine
2021-12-15 | Journal article
DOI: 10.1016/j.esxm.2021.100465
PMID: 34922303
Source: Self-asserted source
Robert Morgan

The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancer.

British Journal of Cancer
2021-10-29 | Journal article
DOI: 10.1038/s41416-021-01605-5
PMID: 34716396
Source: Self-asserted source
Robert Morgan

Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models.

Journal of Experimental & Clinical Cancer Research
2021-10-16 | Journal article
DOI: 10.1186/s13046-021-02124-0
PMID: 34656146
PMC: PMC8520217
Source: Self-asserted source
Robert Morgan

Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.

Genome Medicine
2021-09-01 | Journal article
DOI: 10.1186/s13073-021-00952-5
PMID: 34470661
PMC: PMC8408985
Source: Self-asserted source
Robert Morgan

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study.

BMC Cancer
2021-04-01 | Journal article
DOI: 10.1186/s12885-021-08097-9
PMID: 33794823
PMC: PMC8017714
Source: Self-asserted source
Robert Morgan

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.

British journal of cancer
2021-03-15 | Journal article
DOI: 10.1038/s41416-021-01310-3
PMID: 33723392
PMC: PMC8110747
Source: Self-asserted source
Robert Morgan

DNA replication stress and emerging prospects for PARG inhibitors in ovarian cancer therapy.

Progress in biophysics and molecular biology
2021-01-29 | Journal article
DOI: 10.1016/j.pbiomolbio.2021.01.004
PMID: 33524442
Source: Self-asserted source
Robert Morgan

Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.

The Lancet Oncology
2020-12-22 | Journal article
DOI: 10.1016/s1470-2045(20)30591-x
PMID: 33357510
Source: Self-asserted source
Robert Morgan

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer.

Cancers
2020-12-09 | Journal article
DOI: 10.3390/cancers12123704
PMID: 33317202
PMC: PMC7763954
Source: Self-asserted source
Robert Morgan

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England.

European Journal of Human Genetics
2020-07-10 | Journal article
DOI: 10.1038/s41431-020-0692-y
PMID: 32651552
PMC: PMC7575602
Source: Self-asserted source
Robert Morgan

First-Line Management of Advanced High-Grade Serous Ovarian Cancer.

Current Oncology Reports
2020-06-04 | Journal article
DOI: 10.1007/s11912-020-00933-8
PMID: 32494876
PMC: PMC7270049
Source: Self-asserted source
Robert Morgan

A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity.

Nature Communications
2020-02-13 | Journal article
DOI: 10.1038/s41467-020-14551-2
PMID: 32054838
PMC: PMC7018727
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial.

Gynecologic Oncology
2020-01-10 | Journal article
DOI: 10.1016/j.ygyno.2020.01.005
PMID: 31932108
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Palliative home parenteral nutrition in patients with ovarian cancer and malignant bowel obstruction: experiences of women and family caregivers.

BMC Palliative Care
2019-12-29 | Journal article
DOI: 10.1186/s12904-019-0507-5
PMID: 31884962
PMC: PMC6936090
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer.

ESMO Open
2019-03-21 | Journal article
DOI: 10.1136/esmoopen-2018-000463
PMID: 30962962
PMC: PMC6435240
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors.

Cancer Cell
2019-03-01 | Journal article
DOI: 10.1016/j.ccell.2019.02.004
PMID: 30889383
PMC: PMC6428690
Source: Self-asserted source
Robert Morgan

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.

Journal of Medical Genetics
2019-01-25 | Journal article
DOI: 10.1136/jmedgenet-2018-105792
PMID: 30683677
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer.

International Journal of Gynecological Cancer
2019-01-23 | Journal article
DOI: 10.1136/ijgc-2018-000067
PMID: 30674568
Source: Self-asserted source
Robert Morgan

Rapid reversal of clinical down-classification of a BRCA1 splicing variant avoiding psychological harm.

Clinical Genetics
2018-12-26 | Journal article
DOI: 10.1111/cge.13488
PMID: 30586678
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.

Pancreatology
2018-10-15 | Journal article
DOI: 10.1016/j.pan.2018.10.003
PMID: 30529068
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Abiraterone acetate: a potential source of interference in testosterone assays.

Clinical chemistry and laboratory medicine
2018-05-01 | Journal article
DOI: 10.1515/cclm-2017-0631
PMID: 29303767
Source: Self-asserted source
Robert Morgan

Bilateral Testicular Germ Cell Tumors: A Case-Series From a UK-Based Tertiary Referral Center Over 19 Years.

Clinical genitourinary cancer
2018-03-02 | Journal article
DOI: 10.1016/j.clgc.2018.02.020
PMID: 29566999
Source: Self-asserted source
Robert Morgan

An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer.

International Journal of Gynecological Cancer
2018-03-01 | Journal article
DOI: 10.1097/igc.0000000000001194
PMID: 29466253
Source: Self-asserted source
Robert Morgan

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer.

Cancer Chemotherapy and Pharmacology
2018-02-20 | Journal article
DOI: 10.1007/s00280-018-3532-9
PMID: 29464354
PMC: PMC5854713
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

A National Registry Analysis of Kidney Allografts Preserved With Marshall's Solution in the United Kingdom.

Transplantation
2016-11-01 | Journal article
DOI: 10.1097/tp.0000000000001033
PMID: 26760566
Source: Self-asserted source
Robert Morgan

Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.

Current oncology reports
2016-09-01 | Journal article
DOI: 10.1007/s11912-016-0544-7
PMID: 27484062
Source: Self-asserted source
Robert Morgan

The effect of preservation solutions for storage of liver allografts on transplant outcomes: a systematic review and meta-analysis.

Annals of surgery
2014-07-01 | Journal article
DOI: 10.1097/sla.0000000000000402
PMID: 24374537
Source: Self-asserted source
Robert Morgan

Effect of introduction of antibiotic-impregnated shunt catheters on cerebrospinal fluid shunt infection in children: a large single-center retrospective study.

Journal of neurosurgery. Pediatrics
2013-11-08 | Journal article
DOI: 10.3171/2013.10.peds13189
PMID: 24206346
Source: Self-asserted source
Robert Morgan

A leak too far--gastro-pleural fistula mimicking recurrence of repaired congenital diaphragmatic hernia following fundoplication.

Journal of radiology case reports
2013-09-01 | Journal article
DOI: 10.3941/jrcr.v7i9.1505
PMID: 24421956
PMC: PMC3888184
Source: Self-asserted source
Robert Morgan

Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes.

The British journal of surgery
2013-07-01 | Journal article
DOI: 10.1002/bjs.9169
PMID: 23754643
Source: Self-asserted source
Robert Morgan

Effective prevention of thromboembolic complications in emergency surgery patients using a quality improvement approach.

BMJ quality & safety
2013-05-24 | Journal article
DOI: 10.1136/bmjqs-2013-001855
PMID: 23708440
Contributors: Robert Morgan
Source: Self-asserted source
Robert Morgan
grade
Preferred source (of 2)‎

Systematic reviews of alemtuzumab in renal transplantation.

Transplant immunology
2013-01-23 | Journal article
DOI: 10.1016/j.trim.2013.01.004
PMID: 23352935
Source: Self-asserted source
Robert Morgan

Management of giant omphalocele: a case series.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
2012-10-23 | Journal article
DOI: 10.1055/s-0032-1322538
PMID: 23093432
Source: Self-asserted source
Robert Morgan

Surgical correction of tracheo-oesophageal fistula and oesophageal atresia in infants with VACTERL association: a retrospective case-control study.

Pediatric surgery international
2012-08-22 | Journal article
DOI: 10.1007/s00383-012-3165-8
PMID: 22991204
Source: Self-asserted source
Robert Morgan
Items per page:
Page 1 of 2
How many people are using ORCID?